by GlobeNewsWire | May 23, 2016 | Globe Newswire
MADISON, Wis., May 23, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the 2016 Marcum MicroCap Conference at the Grand Hyatt in New York...
by GlobeNewsWire | May 12, 2016 | Globe Newswire
MADISON, Wis., May 12, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces its financial results for the first quarter of 2016. During the first quarter of 2016, the company reported...
by GlobeNewsWire | May 4, 2016 | Globe Newswire
MADISON, Wis., May 04, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces that management will host a teleconference and live webcast to report first quarter 2016 financial results,...
by GlobeNewsWire | Apr 20, 2016 | Globe Newswire
MADISON, Wis., April 20, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB) today announces the closing of its underwritten public offering of approximately 1.87 million shares of its common stock and approximately 1.91 million pre-funded warrants...
by GlobeNewsWire | Apr 15, 2016 | Globe Newswire
MADISON, Wis., April 15, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or the “company”) today announced the pricing of an underwritten public offering of common stock, or pre-funded warrants in lieu thereof, at a...